US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 4.6400
  • +0.2200+4.98%
Close May 30 16:00 ET
10.73MMarket Cap-358P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.07%6.68M
-3.29%29.63M
26.55%8.92M
-34.53%5.95M
-13.76%6.41M
18.09%8.35M
33.40%30.64M
35.41%7.05M
47.54%9.08M
34.75%7.43M
Selling and administrative expenses
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
52.75%3.09M
31.31%3.2M
-General and administrative expense
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
52.75%3.09M
31.31%3.2M
Research and development costs
-25.23%4.25M
2.74%19.49M
58.74%6.63M
-45.01%3.28M
-7.52%3.89M
23.10%5.69M
31.56%18.97M
31.42%4.18M
45.67%5.97M
38.33%4.2M
Depreciation amortization depletion
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-21.95%32K
-22.73%34K
-Depreciation and amortization
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-21.95%32K
-22.73%34K
Operating profit
20.07%-6.68M
3.29%-29.63M
-26.55%-8.92M
34.53%-5.95M
13.76%-6.41M
-18.09%-8.35M
-33.40%-30.64M
-35.41%-7.05M
-47.54%-9.08M
-34.75%-7.43M
Net non-operating interest income expense
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
80.00%126K
-62.07%33K
-57.61%39K
Non-operating interest income
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
--126K
--33K
-57.61%39K
Other net income (expense)
3,019.15%1.47M
-209.53%-1.51M
-1,160.53%-1.61M
-96.82%14K
-92.72%45K
-71.52%47K
-79.68%1.38M
-93.42%152K
-73.98%440K
-47.67%618K
Gain on sale of security
3,630.77%1.46M
-178.20%-1.04M
-841.72%-1.12M
-99.76%1K
-94.03%36K
-75.63%39K
-80.16%1.34M
-93.43%151K
-74.91%421K
-48.59%603K
Other non- operating income (expenses)
37.50%11K
-1,255.00%-462K
-49,300.00%-492K
-31.58%13K
-40.00%9K
60.00%8K
0.00%40K
-90.00%1K
46.15%19K
87.50%15K
Income before tax
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
Income tax
Net income
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
Net income continuous Operations
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
Minority interest income
Net income attributable to the parent company
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
-59.68%-6.78M
Basic earnings per share
51.09%-2.02
0.99%-15.1454
-45.86%-5.2454
36.67%-2.85
16.67%-3
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
-100.00%-4.5
-60.00%-3.6
Diluted earnings per share
51.09%-2.02
0.99%-15.1454
-45.86%-5.2454
36.67%-2.85
16.67%-3
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
-100.00%-4.5
-60.00%-3.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.07%6.68M-3.29%29.63M26.55%8.92M-34.53%5.95M-13.76%6.41M18.09%8.35M33.40%30.64M35.41%7.05M47.54%9.08M34.75%7.43M
Selling and administrative expenses -9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M52.75%3.09M31.31%3.2M
-General and administrative expense -9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M52.75%3.09M31.31%3.2M
Research and development costs -25.23%4.25M2.74%19.49M58.74%6.63M-45.01%3.28M-7.52%3.89M23.10%5.69M31.56%18.97M31.42%4.18M45.67%5.97M38.33%4.2M
Depreciation amortization depletion 6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-21.95%32K-22.73%34K
-Depreciation and amortization 6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-21.95%32K-22.73%34K
Operating profit 20.07%-6.68M3.29%-29.63M-26.55%-8.92M34.53%-5.95M13.76%-6.41M-18.09%-8.35M-33.40%-30.64M-35.41%-7.05M-47.54%-9.08M-34.75%-7.43M
Net non-operating interest income expense -38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K80.00%126K-62.07%33K-57.61%39K
Non-operating interest income -38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K--126K--33K-57.61%39K
Other net income (expense) 3,019.15%1.47M-209.53%-1.51M-1,160.53%-1.61M-96.82%14K-92.72%45K-71.52%47K-79.68%1.38M-93.42%152K-73.98%440K-47.67%618K
Gain on sale of security 3,630.77%1.46M-178.20%-1.04M-841.72%-1.12M-99.76%1K-94.03%36K-75.63%39K-80.16%1.34M-93.43%151K-74.91%421K-48.59%603K
Other non- operating income (expenses) 37.50%11K-1,255.00%-462K-49,300.00%-492K-31.58%13K-40.00%9K60.00%8K0.00%40K-90.00%1K46.15%19K87.50%15K
Income before tax 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M-59.68%-6.78M
Income tax
Net income 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M-59.68%-6.78M
Net income continuous Operations 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M-59.68%-6.78M
Minority interest income
Net income attributable to the parent company 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M-59.68%-6.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M-59.68%-6.78M
Basic earnings per share 51.09%-2.020.99%-15.1454-45.86%-5.245436.67%-2.8516.67%-3-14.72%-4.13-72.84%-15.2961-166.38%-3.5961-100.00%-4.5-60.00%-3.6
Diluted earnings per share 51.09%-2.020.99%-15.1454-45.86%-5.245436.67%-2.8516.67%-3-14.72%-4.13-72.84%-15.2961-166.38%-3.5961-100.00%-4.5-60.00%-3.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg